Cisplatin and temozolomide combinatorial treatment triggers hypermutability and immune surveillance in experimental cancer models https://t.co/1t1peNzFzt
ecDNA fuels cancer progression: large, mobile circles of DNA in tumors drive high oncogene copies & rapid genetic changes. Their random spread during cell division increases treatment resistance & tumor evolution. Determining therapeutic vulnerabilities & identifying target compounds to limit ecDNA evolution could open impactful new therapeutic horizons.
https://t.co/KbxIOYRw9f
@CellSymposia #hallmarksofcancer
One of the most amazing meeting ever!!
Check out the amazing list of speakers and outstanding talks!
https://t.co/0sKB8PUkH3
@Albert0Bardelli
A great overview/update of this burgeoning field! Still a lot of unanswered questions, but exciting time ahead! Happy we could contribute to this field and comprehensive overview. Thanks to @BardelliLab for taking the lead.
📢This week in @NatureRevCancer, a joint effort by many groups led by the @BardelliLab on #Cancer Persister cells.
🙌🏻It’s been a pleasure to contribute to this roadmap.
➡️https://t.co/WxQQJrXsEU
Hot off the press! We are proud to share our Roadmap on Cancer Persister Cells just published on @NatureRevCancer, a joint effort with outstanding scientists in the field to outline challenges and (exciting) future perspectives
Persisters: https://t.co/bPlfe5JYQF
Excited to share the #Pezcoller23 Symposium final program, with a tremendous lineup of speakers!
💡 NEW TECHNOLOGIES FOR STUDYING AND TREATING CANCER
🗓️19-20 June 🇮🇹 Trento
⏳ Still few days to register, deadline: 31/05👉 https://t.co/OBkYH3ga7A
@ESOncology recommended event
Today at the #EACRCongress in Torino inspiring talk on liquid biopsy and its clinical application by dr. Marsoni. Do not miss upcoming news in the next months!
@EACRnews@eacr2023
Wonderful talk by Yaara Oren kicking off the session on cancer persisters at #EACR2023. Did you know she trained as microbiologist? Thinking outside the box! @EACRnews@BardelliLab
Amazing overview of the last ten years of research in colorectal cancer pointing towards new exciting ones by Prof. Bardelli at #EACR2023.
@BardelliLab@EACRnews
Today at #EACR2023 Giovanni Crisafulli just presented new super interesting data on T-cell repertoire after temozolomide treatment from the #Arethusatrial patients. What’s next from this proof-of-concept trial? Stay tuned!
@BardelliLab@EACRnews@eacr2023